Latest Approved Therapies for Metastatic Melanoma: What Comes Next?

Nowadays, oncogene-directed therapy and immunotherapy represent the two most promising avenues for patients with metastatic melanoma. The recent oncogene-directed therapeutic, vemurafenib, usually produces high level of tumor shrinkage and survival benefits in many patients with B-RAF (V600E) mutant...

Descripción completa

Detalles Bibliográficos
Autor principal: Menaa, Farid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3595667/
https://www.ncbi.nlm.nih.gov/pubmed/23533766
http://dx.doi.org/10.1155/2013/735282

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3595667/
https://www.ncbi.nlm.nih.gov/pubmed/23533766
http://dx.doi.org/10.1155/2013/735282

Ejemplares similares